NAFLD (non-alcoholic fatty liver disease) is a global epidemic that affects 25% of the world’s population, with its epicentre in the West. Twenty percent of NAFLD patients go on to develop the most ...

Utilize the in vitro 3D Non-alcoholic steatohepatitis (NASH), also known as Metabolic-dysfunction-associated steatohepatitis (MASH) model to expedite the path to effective treatment development.

CAMBRIDGE, England--(BUSINESS WIRE)--CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced its ...

Organ-on-a-chip (OOC) technology aims to more accurately reproduce human physiology in vitro, addressing the limitations of current approaches. This field is advancing rapidly. Image Credit: CN Bio ...